Singapore's Core Inflation Rises Faster in March

-- Singapore's core inflation, which excludes the cost of accommodation and private transport, rose 1.7% year on year in March from 1.4% in the previous month, according to a joint release by the Monetary Authority of Singapore and the Ministry of Trade and Industry on Thursday.

The headline consumer price index, representing overall inflation, climbed 1.8% year on year in the month, due to higher transport and core inflation.

On a month-on-month basis, core inflation inched up 0.1%, while overall inflation was up 0.5%.

Core inflation and overall inflation are currently projected to average 1.5% to 2.5% in 2026, the report said.

Tsukishima Lifts Full-Year Profit Forecast on Backlog Execution and Share Sales

Tsukishima (TYO:6332) now expects full-year profit attributable to owners of parent to reach 16.9 billion yen for the fiscal year ended March 31, up from its previous forecast of 15 billion yen.The water equipment manufacturer raised earnings per share forecasts to 412.43 yen from 380.64 yen initially and net sales estimates to 149 billion yen from 144 billion yen, according to a Tokyo bourse filing on Thursday.The upward revision is driven by progress in executing a substantial backlog of received orders, which has boosted net sales, operating profit, and ordinary profit.Additionally, the company recorded higher extraordinary income from the sale of cross-shareholdings, contributing to the profit increase.As a result, Tsukishima raised its year-end dividend forecast to 43 yen per share from 40 yen per share previously, bringing the total annual dividend to 85 yen per share, higher than the 78 yen paid in the prior fiscal year.

$TYO:6332

Altimmune Prices $225 Million Public Offering; Shares Fall Pre-Bell

Altimmune (ALT) said Wednesday it priced its underwritten public offering, consisting of about 64.3 million common shares and accompanying warrants to buy an about 64.3 million common shares and pre-funded warrants to buy up to about 10.8 million common shares and accompanying warrants to buy about 10.8 million common shares.The combined offering price of each common share and accompanying warrant is $3, while the combined offering price of each pre-funded warrant and accompanying common stock warrant is $2.999.The offering is set to close around Friday.Gross proceeds from the offering, set to close around Friday, are estimated to be about $225 million.Altimmune said it plans to use the net proceeds to fund its upcoming phase 3 trial in metabolic dysfunction-associated steatohepatitis, as well as for working capital and general corporate purposes.The company's shares were down over 13% during Thursday premarket activity.Price: $3.00, Change: $-0.47, Percent Change: -13.45%

$ALT

Singapore's Core Inflation Rises Faster in March

Related Articles

Tsukishima Lifts Full-Year Profit Forecast on Backlog Execution and Share Sales

Altimmune Prices $225 Million Public Offering; Shares Fall Pre-Bell

Nasdaq 100 Futures and S&P Futures Both Down Near 0.6%